Cowealth Medical China Co (SHSE:603122) Inventories, Raw Materials & Components: ¥0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603122 Cowealth Medical China Co Ltd SHSE:603122
41 GF Score
Price ¥10.31
GF Value ¥3.86
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Cowealth Medical China Co Inventories, Raw Materials & Components?

Cowealth Medical China Co SHSE:603122 -9.96% 41 Inventories, Raw Materials & Components is ¥0.0 Mil as of Mar. 2026. GuruFocus rates SHSE:603122 with a GF Score™ of 41/100 and a GF Value™ of ¥3.86 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Cowealth Medical China Co's inventories, raw materials & components for the quarter that ended in Mar. 2026 was ¥0.0 Mil.

Cowealth Medical China Co Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Cowealth Medical China Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cowealth Medical China Co Inventories, Raw Materials & Components Chart

Cowealth Medical China Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cowealth Medical China Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SHSE:603122
41GF Score
Cowealth Medical China Co Ltd SHSE:603122
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cowealth Medical China Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ¥0.0 Mil mean?
Cowealth Medical China Co (SHSE:603122) has a Inventories, Raw Materials & Components of ¥0.0 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Cowealth Medical China Co and its competitors.
Is Cowealth Medical China Co's Inventories, Raw Materials & Components too high?
Cowealth Medical China Co's current Inventories, Raw Materials & Components is ¥0.0 Mil. Overall, Cowealth Medical China Co has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cowealth Medical China Co's Inventories, Raw Materials & Components compare to TMO and DHR?
Cowealth Medical China Co's Inventories, Raw Materials & Components of ¥0.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Diagnostics & Research company?
A good Inventories, Raw Materials & Components depends on the Medical Diagnostics & Research industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Cowealth Medical China Co and its competitors. Cowealth Medical China Co's current Inventories, Raw Materials & Components is ¥0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cowealth Medical China Co stock overvalued right now?
Based on GuruFocus' analysis, Cowealth Medical China Co (SHSE:603122) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥3.86, compared to a current price of ¥10.31 — trading 167.1% above its estimated fair value. The current Inventories, Raw Materials & Components is ¥0.0 Mil. Cowealth Medical China Co's overall GF Score™ is 41/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Cowealth Medical China Co (SHSE:603122), the current Inventories, Raw Materials & Components is ¥0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cowealth Medical China Co (SHSE:603122) Overvalued in 2026?

Based on GuruFocus' analysis, Cowealth Medical China Co stock appears to be overvalued. The current stock price of ¥10.31 is trading 167.1% above its estimated GF Value™ of ¥3.86. GuruFocus considers Cowealth Medical China Co to be Significantly Overvalued.

Key valuation signals for SHSE:603122:

  • Inventories, Raw Materials & Components: ¥0.0 Mil
  • GF Value™: ¥3.86 vs. price of ¥10.31 (167.1% above fair value)
  • GF Score™: 41/100 with 3 warning signs

No single metric tells the full story. See the SHSE:603122 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cowealth Medical China Co Business Description

Address No. 1001 Qinzhou North Road, 21st Floor, Building 12, Xuhui District, Shanghai, CHN, 200131
Cowealth Medical China Co Ltd operates as a diagnostic clinical laboratory company. It has introduced radiation oncology technology into the market.
41GF Score

Get the complete analysis for SHSE:603122

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥10.31
Price
¥3.86
GF Value